Lymphocytes and neutrophils are rapidly depleted by systemic infection 1 . Progenitor cells of the haematopoietic system, such as common myeloid progenitors and common lymphoid progenitors, increase the production of immune cells to restore and maintain homeostasis during chronic infection, but the contribution of haematopoietic stem cells (HSCs) to this process is largely unknown 2 . Here we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-term repopulating HSCs proliferate during M. avium infection, and that this response requires interferon-c (IFN-c) but not interferon-a (IFN-a) signalling. Thus, the haematopoietic response to chronic bacterial infection involves the activation not only of intermediate blood progenitors but of long-term repopulating HSCs as well. IFN-c is sufficient to promote long-term repopulating HSC proliferation in vivo; furthermore, HSCs from IFN-c-deficient mice have a lower proliferative rate, indicating that baseline IFN-c tone regulates HSC activity. These findings implicate IFN-c both as a regulator of HSCs during homeostasis and under conditions of infectious stress. Our studies contribute to a deeper understanding of haematological responses in patients with chronic infections such as HIV/AIDS or tuberculosis [3] [4] [5] .
Lymphocytes and neutrophils are rapidly depleted by systemic infection 1 . Progenitor cells of the haematopoietic system, such as common myeloid progenitors and common lymphoid progenitors, increase the production of immune cells to restore and maintain homeostasis during chronic infection, but the contribution of haematopoietic stem cells (HSCs) to this process is largely unknown 2 . Here we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-term repopulating HSCs proliferate during M. avium infection, and that this response requires interferon-c (IFN-c) but not interferon-a (IFN-a) signalling. Thus, the haematopoietic response to chronic bacterial infection involves the activation not only of intermediate blood progenitors but of long-term repopulating HSCs as well. IFN-c is sufficient to promote long-term repopulating HSC proliferation in vivo; furthermore, HSCs from IFN-c-deficient mice have a lower proliferative rate, indicating that baseline IFN-c tone regulates HSC activity. These findings implicate IFN-c both as a regulator of HSCs during homeostasis and under conditions of infectious stress. Our studies contribute to a deeper understanding of haematological responses in patients with chronic infections such as HIV/AIDS or tuberculosis [3] [4] [5] .
As the precursors of all blood cells, HSCs remain dormant during most of the life of an organism, entering the cell cycle only when necessary to generate differentiated progeny 6, 7 . Maintenance of the blood and immune systems imposes different stresses on HSCs, ranging from the routine demands of cellular senescence to the extreme stress of acute bleeding, when the production of peripheral blood cells must be increased many-fold 8 . The signals that trigger HSC activation remain largely unknown. Because infection is a common natural stressor that leads to the consumption of peripheral immune cells, we sought to determine whether replenishment of immune cells during chronic infection requires only immediate myeloid and lymphoid precursors or if activation of HSCs is also required 9, 10 . Furthermore, we investigated the role of the interferon family of inflammatory cytokines in influencing HSC activation.
Earlier studies by our group and others [11] [12] [13] have noted an increase in the absolute and relative number of primitive progenitor cells of the bone marrow in response to chronic infection. These results were obtained by phenotypically tracking cells that expressed the stem cell markers c-Kit and Sca-1 while lacking the canonical markers of lineage differentiation (so-called KSL cells). Thus far, however, neither the mechanism nor the functional consequence of this change has been fully explored. For instance, the signalling molecules that affect HSCs during infection and whether they promote a proliferative response remain unknown. To address this, we chose a mouse model of M. avium infection, which affords an example of chronic systemic mycobacterial diseases, including tuberculosis 14 , and enables us to study HSCs without disrupting their natural microenvironment.
When injected intravenously (i.v.) with M. avium, wild-type mice were systemically infected with large numbers of bacteria at 4 weeks after injection and had larger spleens, consistent with sequestration of bacteria and lymphoid cells in the spleen ( Supplementary Fig. 1 ) 15 . Despite infection with M. avium, the absolute numbers of lymphocytes, neutrophils, monocytes, eosinophils and basophils in peripheral blood remained stable; the only significant changes in blood composition were a decrease in platelet number at 2 weeks after infection (Supplementary Fig. 2A ) and a relative decrease of B cells with an associated increase of CD4 1 T cells and granulocytes at 4 weeks after infection ( Supplementary Fig. 2B ). The bone marrow showed a loss of granulocyte-monocyte progenitors, common myeloid progenitors, and macrophage-erythroid progenitors from 2 to 4 weeks after infection with a concomitant increase in common lymphoid progenitors ( Supplementary Fig. 3 ). These changes are consistent with mobilization of a T-cell-mediated immune response, characteristic of ongoing mycobacterial disease 15 .
Given the observed changes in intermediate progenitor populations in M. avium-infected mice, we asked whether earlier progenitors might be activated to expand during chronic infection. To assess the response of early haematopoietic progenitors to M. avium infection, we determined the absolute numbers of short-term repopulating HSCs (ST-HSCs; KSL, CD34 1 , Flk2 2 ) and multipotent progenitors (KSL, CD34 1 , Flk2 1 ; gating shown in Supplementary Fig. 4 ) in mice 4 weeks after infection. There was a sharp increase (P , 0.001) in ST-HSCs ( Fig. 1a ), cells that are highly proliferative and can maintain pluripotency for several weeks 16 . These findings indicate that compensatory expansion of these progenitors maintains blood cell homeostasis over the course of a chronic M. avium infection.
To assess the effect of mycobacterial infection on the most primitive progenitor populations of the bone marrow, we analysed the long-term repopulating HSCs (LT-HSCs). LT-HSCs were phenotypically defined by surface markers (KSL, CD34 2 , Flk2 2 or KSL, CD150 1 ) 16, 17 or a combination of vital dye staining and surface markers (side population (SP) with KLS, SP KLS ) 18 . Where experimentally possible, we conducted experiments using several phenotypic definitions of LT-HSCs to verify that our observations were not due to stress-induced alterations in marker expression. After observing M. avium infection in wild-type animals for 4 weeks after infection, we found that the absolute numbers of LT-HSCs were increased marginally (KSL, Flk2 -, CD34 -; Fig. 1a ) or not at all (SP KLS ; Fig. 1b ).
The expansion in ST-HSCs with minimal increase in LT-HSC number indicated that the LT-HSCs may be proliferating to meet the increased demand for their immediate downstream progeny, namely ST-HSCs and multipotent progenitors. To examine this possibility, we determined the proliferative status of the LT-HSCs during M. avium infection by measuring their relative incorporation of 5-bromo-29-deoxyuridine (BrdU) 19 . The results demonstrated an increased percentage of proliferating LT-HSCs (SP KLS ) in the bone marrow of infected mice compared with the level before infection ( Fig. 1c ). We also confirmed these findings by Hoechst and pyronin Y staining to assess the cell-cycle status of HSCs from uninfected and infected animals 19 . The M. avium infected mice had a significantly lower percentage of quiescent (G 0 ) HSCs compared to uninfected mice ( Supplementary Fig. 5 ). Thus, M. avium infection seems to stimulate an increase in the proliferative fraction of primitive LT-HSCs, along with a substantial increase in the numbers of early committed progenitors.
If the proliferative fraction of LT-HSCs from infected mice is indeed increased, such cells may be expected to lose some regenerative function and to engraft less readily than HSCs from uninfected mice, as has been shown for proliferating HSCs 20 . To test this, we transplanted 500 LT-HSCs from naive or M. avium-infected mice into irradiated wildtype CD45.1 recipients together with a radioprotective dose of 2 3 10 6 recipient-type CD45.1 whole bone marrow cells. At short time points after transplantation, the LT-HSCs from infected mice showed impaired engraftment compared with those from uninfected mice, consistent with their increased proliferative status ( Fig. 1d ). Of note, few if any M. avium bacteria could be isolated from the donor whole bone marrow, and no bacteria were isolated from the spleens of recipient mice 20 weeks after transplantation, indicating that infectious particles were not transmitted with the cell transplants. We conclude from these data that chronic mycobacterial infection induces proliferation of HSCs, with functional consequences that cannot be attributed to infection of the stem cells themselves.
Given the finding that LT-HSCs are more highly proliferative during chronic M. avium infection without a large change in their absolute number in the bone marrow, we wondered if the cells were being increasingly mobilized to leave the bone marrow during infection. To assess this possibility, we measured the number of LT-HSCs detectable in the spleen after infection. Infection with M. avium led to a notable increase in the number of phenotypic HSCs in the spleen ( Fig. 1e ), suggesting mobilization of some of these cells during infection.
Soon after infectious stress is imposed, haematopoietic progenitors begin to proliferate to restore homeostasis, yet the signalling pathways involved in this response are largely unknown 10, 21 . Because IFN-c is strongly upregulated during M. avium infection 15, 22 , we focused our attention on the interferons 23 . We hypothesized that IFN-c is responsible for the proliferative response of HSCs during M. avium infection. To confirm that M. avium infection in mice leads to an increase of IFN-c in bone marrow, where HSCs reside, we collected bone marrow supernatants from naive and infected mice at 4 weeks after infection. Consistent with previous findings in serum 15, 22 , analysis of the samples by a cytokine bead array method indicated strong upregulation of IFN-c in the bone marrow of mice infected with M. avium ( Fig. 2a ).
Because many different cytokines are active during periods of infectious stress, we sought to determine if IFN-c is necessary to influence the behaviour of HSCs. We predicted that interference with IFN-c signalling would abrogate the HSC response to M. avium infection. Therefore, we analysed the HSCs in bone marrow samples from naive and infected mice lacking essential components of the IFN-c signalling pathway, including mice lacking the IFN-c receptor 1 (Ifngr1) gene or the Stat1 gene encoding the downstream signal transducer for IFN-c receptor subunit 1 (Ifngr1). Animals lacking functional Ifngr1 or Stat1 showed an impaired proliferative response of the LT-HSC compartment as measured by BrdU incorporation (Fig. 2b ). However, proliferative activation of LT-HSCs occurred normally in mice lacking functional IFN-a receptor 1 (Ifnar1), suggesting that IFN-a signalling is not required for this response (Fig. 2b) . Similarly, the modest numerical increase observed in phenotypically defined HSCs in response to infection was abrogated in IFNc-signalling mutants (Fig. 2c ). Furthermore, when the same infection was carried out in mice lacking Ifnar1, the HSC response was intact. These results collectively support an essential role for IFN-c but not IFN-a in the proliferative activation of HSCs in response to in vivo infection by M. avium. We next turned our attention to determine whether LT-HSCs respond directly to IFN-c stimulation, and whether IFN-c alone is sufficient to induce these effects. Previous work from our group indicated that LT-HSCs express Ifngr1, allowing them to respond directly to IFN-c signalling 24 . We confirmed that Ifngr1 is expressed by HSCs using real-time quantitative polymerase chain reaction (PCR) analysis (Fig. 3a) . Indeed, the amount of Ifngr1 messenger RNA in HSCs was significantly higher than that in T cells, B cells and granulocytes, all known to express high levels of this receptor 25 . To assess the function of Ifngr1 on LT-HSCs, we treated purified LT-HSCs with IFN-c in vitro and examined them for changes in mRNA levels of a known IFN-inducible gene, Irgm1 (ref. 26) . We found that Irgm1 expression is upregulated in response to IFN-c exposure in vitro, and that this response is abrogated in Ifngr1-deficient and Stat1-deficient HSCs (Fig. 3b) . These results were confirmed by an increase in Irgm1 protein levels in IFN-c-treated versus untreated mouse HSCs stained with anti-IRGM1 antibody and fluorescein isothiocyanate (FITC)-conjugated secondary antibody (green) (Fig. 3c ). Furthermore, other interferon-regulated genes including Stat1, Irf1 and Irf9 were upregulated in HSCs after in vitro IFN-c exposure when measured by real-time quantitative PCR, indicating that typical IFN-c signalling pathways were activated in the purified cells ( Supplementary  Fig. 6 ) 27 .
These findings indicated that HSC proliferation could be triggered with purified mouse recombinant IFN-c (rIFN-c) alone. We measured HSC proliferation in response to induction by rIFN-c in vitro, and we found that primitive haematopoietic cells are significantly more proliferative after rIFN-c treatment (Fig. 3d) , with no increase in apoptosis ( Supplementary Fig. 7 ). This rapid in vitro response suggests the IFN-c-dependent effects on the HSCs are independent of other physiological changes in the bone marrow.
To determine if these effects also occurred in vivo, we injected wildtype mice intravenously with 10 mg of rIFN-c, injected them with BrdU 12 h later and analysed the proliferative status of the HSCs after 12 further hours. Analysis of BrdU incorporation into LT-HSCs from treated and untreated mice showed a significant increase in the percentage of proliferating stem cells in response to IFN-c treatment ( Fig. 4a ). Transplants using whole bone marrow from rIFN-c-treated mice showed modest impairment in the functional reconstitution capacity of rIFN-c-exposed cells compared to whole bone marrow from untreated mice (Fig. 4b) . Finally, increased mobilization of primitive haematopoietic cells to the spleen could also be detected after in vivo treatment with purified IFN-c (Fig. 4c ). Together, these experiments demonstrate that IFN-c directly affects HSCs and that exposure to IFN-c alone is sufficient to induce their proliferation and mobilization.
Given our finding that IFN-c is both necessary and sufficient for HSC proliferation and mobilization during M. avium infection, we proposed that mice lacking the IFN-c cytokine may show alterations in their HSC compartments. When we investigated the bone marrow of IFN-c-deficient mice, we found that LT-HSCs were less proliferative even in the absence of infection (Fig. 5a ), but the total number of phenotypically defined LT-HSCs did not differ between wild-type and IFN-c-deficient mice ( Supplementary Fig. 8 ). We tested the functional capacity of the Ifng 2/2 HSCs in noncompetitive transplants (2 3 10 6 donor whole bone marrow cells) and competitive transplants (2 3 10 6 donor whole bone marrow cells competing against 2 3 10 6 CD45.1 whole bone marrow cells). Consistent with their decreased baseline proliferative status, HSCs from IFN-cdeficient mice showed improved engraftment compared to wild-type HSCs in competitive transplant assays (Fig. 5b) . Because the phenotypic HSC number seems to be the same in wild-type and IFN-cdeficient mice, the improved engraftment probably results from the higher level of quiescence, as this property is inextricably linked to engraftment potential and HSC quality 7, 20 . These results indicate that IFN-c stimulates HSCs even in the steady state, and that baseline IFN-c tone may influence HSC turnover and quality during normal homeostasis.
This work provides evidence that LT-HSCs can respond directly to IFN-c stimulation in the context of a chronic infection. The LT-HSC numbers, defined phenotypically and functionally, remain relatively constant, but a larger proportion are in cycle. This activation is accompanied by a substantial increase in the number of immediate downstream progenitors and maintenance of stable numbers of differentiated peripheral blood cells. These findings indicate that IFN-c promotes proliferation of HSCs to feed the generation of immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process. A recent report found that acute treatment of mice with purified IFN-a or the IFN-a-inducing agent poly(I:C) leads to cell-autonomous HSC proliferation, which was absent in Ifnar 2/2 and Stat1 2/2 mice 28 . In that study, HSCs lacking the IFN-a receptor were still able to respond to IFN-a treatment when mixed with a high percentage of wild-type cells, indicating that other signalling pathways can compensate for the lack of IFN-a in HSC activation. Our study raises the possibility that IFN-a and IFN-c serve redundant functions to activate HSCs in the context of an infection, possibly in a pathogen-specific manner.
A working model of IFN-c-mediated stimulation of quiescent HSCs with increased proliferation and mobilization during a chronic bacterial infection is shown in Supplementary Fig. 9 . In contrast with the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFN-c under normal physiological conditions, our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFN-c, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool. Although cell division is required for HSCs to generate large numbers of downstream progenitors to replenish a stressed haematopoietic system, sustained HSC proliferation has repeatedly been shown to compromise long-term HSC quality and bone marrow transplant capacity 7, 20 . We show here that increased proliferation in the context of chronic infection or direct exposure to IFN-c can lead to at least a transient impairment of HSC function. We speculate that in some contexts, chronic infection or inflammation can ultimately lead to more substantive deficits in the ability of the LT-HSC compartment to sustain blood production. Deepened understanding of the molecular mechanisms used by HSCs to respond to chronic inflammatory stimuli could lead to improved clinical insight into the pathophysiology of bone marrow suppression in patients with chronic infections such as tuberculosis and HIV/AIDS 3, 4 .
METHODS SUMMARY
Mice. Mice were 6 to 12 weeks of age, including wild-type C57BL/6 (CD45.2), wild-type C57BL/6.SJL (CD45.1), C57BL/6 Ifng 2/2 and C57BL/6 Ifngr1 2/2 mice from Jackson Laboratories, C57BL/6 Stat 2/2 mice from D. Levy and C57BL/6 Ifnar1 2/2 mice from C. Schindler. Mycobacterial infection and interferon treatment. Mice were infected i.v. with 2 3 10 6 colony-forming units of M. avium as described 29 . For IFN-c treatments, HSCs were incubated with 100 ng ml 21 rIFN-c (R&D) at 37 uC for 1 h before real-time PCR, 12 h for BrdU analysis, and 18 h before immunofluorescence. For in vivo treatments, each mouse was injected with 10 mg IFN-c i.v. Flow cytometry and BrdU analysis. Peripheral blood was analysed with a Hemavet 950. MoFlo, LSRII and FACS-Scan instruments were used for flow cytometric analysis and sorting. Progenitor and HSC populations were identified and HSC BrdU analysis was performed as described 21 . Immunohistochemistry. HSCs were stained with anti-IRGM1 antibody (1:100 v/v) (Santa Cruz sc-11077) by standard methods. Images were gathered with a DeltaVision restoration microscope and Softworx imaging software. Quantitative real-time PCR and cytokine detection. Irgm1, Ifngr1, Stat1, Irf1 and Irf9 probes were used with Taqman PCR Mastermix and a 7900HT Fast Real-Time PCR system. Triplicate samples were normalized to internal 18S controls (Applied Biosystems).
IFN-c levels were determined using an IFN-c BD cytokine bead array and BD FacsArray plate reader. The protein content of the bone marrow supernatant was quantified using a NanoDrop spectrophotometer (NanoDrop Technologies). Transplants. For bone marrow transplants, a mixture of test CD45.2 whole bone marrow and wild-type CD45.1 whole bone marrow was injected i.v. into CD45.1 mice that were irradiated with a split dose of 10.5 gray (Gy), as described 13 . Engraftment was assessed at 4-week intervals. Statistics. Mean values 6 s.e.m. are shown. Student's t-test or ANOVA were used for comparisons (GraphPad Prism Version 5.0). *P , 0.05, **P , 0.01, ***P , 0.001. 
